tiprankstipranks
Advertisement
Advertisement

ACXP Stock Latest News

Acurx announces FDA conditional approval of CIFBEZY as brand name for ibezapolst
The FlyAcurx announces FDA conditional approval of CIFBEZY as brand name for ibezapolst
7d ago
ACXP
Acurx receives patents for DNA Polymerase IIIC inhibitors in Mexico and Japan
PremiumThe Fly
Acurx receives patents for DNA Polymerase IIIC inhibitors in Mexico and Japan
7d ago
ACXP
Acurx reports Q2 EPS (53c) vs. ($1.89) last year
PremiumThe Fly
Acurx reports Q2 EPS (53c) vs. ($1.89) last year
8d ago
ACXP
Acurx Pharmaceuticals Earnings Call Highlights Funding Risk
PremiumCompany Announcements
Acurx Pharmaceuticals Earnings Call Highlights Funding Risk
9d ago
ACXP
ACXP Advances Ibezapolstat Trial in High-Risk C. Difficile Patients
PremiumCompany Announcements
ACXP Advances Ibezapolstat Trial in High-Risk C. Difficile Patients
12d ago
ACXP
ACXP Earnings this Week: How Will it Perform?
PremiumPre-EarningsACXP Earnings this Week: How Will it Perform?
12d ago
ACXP
Acurx partners with Leiden University Medical Center to develop its antibiotics
Premium
The Fly
Acurx partners with Leiden University Medical Center to develop its antibiotics
14d ago
ACXP
Acurx announces outcome of meeting with FDA on ibezapolstat’s clinical program
Premium
The Fly
Acurx announces outcome of meeting with FDA on ibezapolstat’s clinical program
21d ago
ACXP
Acurx’s ibezapolstat shows microbe preservation efficacy
PremiumThe Fly
Acurx’s ibezapolstat shows microbe preservation efficacy
1M ago
ACXP
Acurx Pharmaceuticals Charts Risky but Promising CDI Path
PremiumCompany Announcements
Acurx Pharmaceuticals Charts Risky but Promising CDI Path
3M ago
ACXP
Acurx reports Q1 EPS (62c) vs. ($2.15) last year
PremiumThe Fly
Acurx reports Q1 EPS (62c) vs. ($2.15) last year
3M ago
ACXP
Acurx files to sell 1.65M shares of common stock for holders
PremiumThe Fly
Acurx files to sell 1.65M shares of common stock for holders
4M ago
ACXP
Acurx files to sell 1.3M shares of common stock for holders
PremiumThe FlyAcurx files to sell 1.3M shares of common stock for holders
4M ago
ACXP
Acurx announces $7.1M registered direct offering priced at-the-market
Premium
The Fly
Acurx announces $7.1M registered direct offering priced at-the-market
4M ago
ACXP
Acurx Pharmaceuticals Secures New Financing to Advance Pipeline
Premium
Company Announcements
Acurx Pharmaceuticals Secures New Financing to Advance Pipeline
4M ago
8K
ACXP
New to The Street announce re-signing of Acurx Pharmaceuticals
PremiumThe Fly
New to The Street announce re-signing of Acurx Pharmaceuticals
5M ago
ACXP
Acurx: KIPO grantes new patent covering DNA Polymerase IIIC inhibitors
PremiumThe Fly
Acurx: KIPO grantes new patent covering DNA Polymerase IIIC inhibitors
5M ago
ACXP
Acurx price target lowered to $10 from $20 at Alliance Global
PremiumThe Fly
Acurx price target lowered to $10 from $20 at Alliance Global
5M ago
ACXP
Acurx reports Q4 EPS (73c) vs. ($3.29) last year
PremiumThe Fly
Acurx reports Q4 EPS (73c) vs. ($3.29) last year
5M ago
ACXP
Acurx Pharmaceuticals Stock (ACXP) Explodes 218% as New Trial Moves Forward on 96% Cure Rate
PremiumMarket NewsAcurx Pharmaceuticals Stock (ACXP) Explodes 218% as New Trial Moves Forward on 96% Cure Rate
5M ago
ACXP
ACXP Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ACXP Earnings this Week: How Will it Perform?
6M ago
ACXP
Acurx Advances Ibezapolstat Program for Recurrent C. difficile
Premium
Company Announcements
Acurx Advances Ibezapolstat Program for Recurrent C. difficile
6M ago
8K
ACXP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >